baber/WOPTO huggingface dataset:
Patent NZ-586011-A (NZ)
Title: A foaming composition having suspended particles adapted for use in a non-aerosol dispenser
Inventor: MATTHEWS SHAUN KERRY
IPC: C11D3/50
Filed: 2005-05-06
Abstract: Disclosed herein is a foaming composition which comprises a liquid including a plurality of particles with a mean particle size between 90 and 700 microns suspended therein, water, at least one surfactant, and at least one non-Newtonian thickener, wherein the non-Newtonian thickener exhibits viscosity at low shear rates that is sufficient to maintain particles suspended in the liquid and has low viscosity when exposed to high shear rates, the liquid being foamable when mixed and dispensed with air from a non-aerosol dispenser, the dispensed foam having the plurality of particles suspended therein when mixed with air, wherein said particles may be chosen from the group consisting of pumice, cornmeal, ground walnut shells, ground fruit stones, wood flour, microbeads, microcapsules, dried pulses and any combination thereof, wherein said composition is adapted for use in a non-aerosol dispenser comprising a foaming component including:(a) an air sparging element chosen from a group consisting of sintered polyethylene, sintered bronze, sintered stainless steel, micro porous materials, and multi-layer stainless steel gauze;(b) a mixing chamber on one side of the air sparging element and the air sparging element defining a portion of the mixing chamber and the mixing chamber having a liquid inlet in flow communication with the liquid container;(c) a foaming component air chamber on the other side of the air sparging element and the air sparging element defining a portion of the air chamber and the air chamber having an air inlet; and (d) a mixing chamber outlet downstream of the liquid inlet in the mixing chamber. The disclosure also provides that the foaming composition is adapted for use in a method of making foam including the steps of: (a) providing air under pressure to one side of an air sparging element chosen from a group consisting of sintered polyethylene, sintered bronze, sintered stainless steel, micro porous materials, and multi-layer stainless steel gauze; (b) providing the liquid under pressure to a mixing chamber on the other side of the air sparging element; (c) pushing the air through the sparging element into the mixing chamber; and (d) mixing the air and the liquid thereby creating foam.
Patent NZ-587305-A (NZ)
Title: Anti-tyrosinase-realted protein-1 (TYRP1) antibodies
Inventor: KANG XIAOQIANG
IPC: A61K39/395
Filed: 2009-03-11
Abstract: A monoclonal antibody that specifically binds to human TYRP1 (SEQ ID NO. 28) and comprises a VH chain with the amino acid sequence: QVQLVQSGSELKKPGASVKISCKASGYTFTSYAMNWVRQAPGQGLESMGWINTNTGNPTYAQGFTGRFVFSMDTSVSTAYLQISSLKAEDTAIYYCAPRYSSSWYLDYWGQGTLVTVSS (SEQ ID NO: 14), a CDRL1 having the sequence RASQSVSSYLA (SEQ ID NO: 4), a CDRL2 having the sequence DASNRAT (SEQ ID NO: 5), and a CDRL3 having the sequence QQRSNWLMYT (SEQ ID NO: 6). The antibody can be used to treat malignant melanoma.
Patent NZ-592656-A (NZ)
Title: Ethylenically unsaturated, polymerisable UV-absorbing compounds and their use in the preparation of ophthalmic lenses
Inventor: DOMSCHKE ANGELIKA MARIA
IPC: C07D249/20
Filed: 2009-12-17
Abstract: Disclosed is a compound of formula I, comprising: an ultraviolet absorber, a polymerization initiator directly or indirectly bonded to the ultraviolet absorber, and an ethylenically unsaturated group directly or indirectly bonded to the ultraviolet absorber, wherein Z is a divalent radical of formula (1a). The polymerization initiator moiety is selected from the group consisting of phosphine oxide, a peroxide group, an azide group, an alpha-hydroxyketone, and an alpha-aminoketone. The compound of formula I is useful for making ophthalmic lenses, including contact lenses and intraocular lenses, capable of blocking ultraviolet (UV) radiation.
Patent NZ-592713-A (NZ)
Title: Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
Inventor: RAPPUOLI RINO
IPC: A61K39/145
Filed: 2006-11-06
Abstract: Disclosed is an immunogenic composition comprising: (i) an influenza virus antigen; (ii) an oil-in-water emulsion adjuvant; and (iii) a cytokine-inducing agent that is an agonist of a human Toll-Like Receptor 9 (TLR 9) protein.
Patent NZ-596435-A (NZ)
Title: Lens with controlled backlight management
Inventor: WILCOX KURT S
IPC: F21V5/00
Filed: 2010-05-04
Abstract: A lens distributing light, predominantly toward a preferential side, from a light emitter having an emitter axis and defining an emitter plane has an emitter-adjacent base end forming an emitter-receiving opening to an emitter-surrounding cavity having an inner surface which includes a front sector centered on the preferential side and a back sector centered on the radially opposite non-preferential side. The front and back sectors differ in their respective configurations for refracting light from the emitter. The lens further includes an primary back surface positioned and configured to receive and totally reflect light from at least a portion of the inner-surface back sector The inner-surface back sector and the primary back surface extend along substantially elliptical cross-sections in planes substantially parallel to the emitter plane. The base end forms a back opening to a back cavity substantially centered on the non-preferential side and partially bounded by the primary back surface.
Patent NZ-598933-A (NZ)
Title: Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
Inventor: HALCOMB RANDALL L
IPC: A61K31/522
Filed: 2010-10-15
Abstract: ABSTRACT - 598933 The disclosure relates to biaryl purine and 3-deazapurine derivatives represented by of formula (I), wherein the variables are as defined in the specification. These of purine or deazapurine derivatives selectively modulate toll-like receptors (such as TLR-7) and are useful for the treatment of (inter alia) viral infections, and are also suitable for the treatment or prevention of melanoma, non-small cell lung carcinoma, hepatocellular carcinoma, basal cell carcinoma, renal cell carcinoma, myeloma, allergic rhinitis, asthma, COPD, ulcerative colitis, hepatic fibrosis, HBV, HCV, HPV, RSV, SARS, HIV, or influenza.
Patent NZ-599941-A (NZ)
Title: Abt-263 capsule
Inventor: TONG PING
IPC: A61K9/48
Filed: 2010-12-21
Abstract: Disclosed is a pharmaceutical capsule comprising a capsule shell having encapsulated therewithin, in an amount not greater than about 1000 mg per capsule, a liquid solution of navitoclax (ABT-263 / N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide) or a pharmaceutically acceptable salt thereof at a navitoclax free-base equivalent concentration of at least about 40 mg/ml in a substantially non-ethanolic carrier that comprises as pharmaceutically acceptable excipients (a) at least one phospholipid (such as phosphatidylcholine), (b) at least one solubilizing agent for the at least one phospholipid, selected from the group consisting of glycols, glycolides, glycerides and mixtures thereof (particularly mixtures of medium-chain triglycerides and one or more medium-chain mono- and/or diglycerides), (c) at least one non-phospholipid surfactant in an amount of 7% to 30% of the encapsulated liquid (such as polysorbate 80), and (d) at least one sulfur-containing antioxidant (such as sulfites, bisulfites, metabisulfites, thiosulfates and mixtures thereof) in an amount effective to reduce oxidative degradation of navitoclax upon storage.
Patent NZ-602220-A (NZ)
Title: Antibodies with ph dependent antigen binding
Inventor: RAJPAL ARVIND
IPC: C07K16/40
Filed: 2011-03-09
Abstract: Discloses an antibody that specifically binds to PCSK9 comprising the specified heavy and light chains disclosed in SEQ ID NOs: 4 or 5 and SEQ ID NO: 6 respectively. Further discloses plasmids, host cells and pharmaceutical compositions comprising said antibodies.
Patent NZ-603933-A (NZ)
Title: Gravity feed water treatment system
Inventor: SCHAMPER RYAN D
IPC: C02F1/00
Filed: 2010-01-12
Abstract: 603933 Disclosed is a chlorinator device for a water treatment system (see figure 34) for chlorinating water with a chlorine tablet (3506). The device comprises a chlorinator inlet (3500) for receiving unchlorinated water, a chlorine capsule (3504), a bypass outlet (3512) for dispensing unchlorinated water, a flow container (3502) for directing water from the chlorinator inlet to either the chlorine capsule or to the bypass outlet, and a chlorinator outlet (3510) for recombining the unchlorinated water from the bypass outlet and the chlorinated water from the chlorine capsule. The chlorine tablet is disposed within the chlorine capsule. The chlorine capsule comprises a chlorine capsule inlet defined by a plurality of slots (3514) in a side wall, and a chlorine capsule outlet. The slots of the chlorine capsule inlet are configured to regulate the amount of water entering the chlorine capsule, thereby controlling the exposure of the chlorine tablet to the water entering the chlorine capsule. The chlorine capsule outlet dispenses the chlorinated water. A tablet support (3518) may also be provided within the chlorine capsule to only expose a portion of the chlorine tablet to the water entering the chlorine capsule.
Patent NZ-606597-A (NZ)
Title: Synthesis for thiazolidinedione compounds
Inventor: TANIS STEVEN P
IPC: C07D417/12
Filed: 2011-08-09
Abstract: The disclosure relates to methods for synthesizing PPAR( sparing compounds, particularly thiazolidinedione derivatives of formula (I), wherein the variables are as defined in the specification. Peroxisome Proliferator Activated Receptors (PPARs) are members of the nuclear hormone receptor super-family, which are ligand-activated transcription factors regulating gene expression, thus PPAR( is the generally accepted site of action for insulin sensitizing thiazolidinedione compounds, which makes these thiazolidinedione compounds useful for preventing and/or treating metabolic disorders such as diabetes, obesity, hypertension, dyslipidemia, and inflammatory diseases.
Patent NZ-606903-A (NZ)
Title: Methods for the treatment or prophylaxis of thrombosis or embolism
Inventor: KUMAR ASHOK
IPC: C07D495/04
Filed: 2011-08-25
Abstract: Disclosed herein is the use the S-enantiomer of anti-platelet drug oxo-clopidogrel or the derivative of formula IIA in the manufacture of a medicament for alleviating inter-individual platelet response variability and metabolic loading in humans in the treatment of thrombosis or embolism. Compositions for use in such methods comprising an (S)-oxo-clopidogrel or its derivative of the Formula IIA or a pharmaceutically acceptable salt thereof are also provided.
Patent NZ-618350-A (NZ)
Title: Cutting insert for a foodstuff chopping apparatus
Inventor: CEDOMIR REPAC
IPC: B26D5/10
Filed: 2012-05-04
Abstract: A cutting insert (1) having a first cutting blade arrangement (2) for a foodstuff chopping apparatus, which has a ram for pushing material to be chopped through the cutting insert. The first cutting blade arrangement (2) is arranged in a first region (3) of the cutting insert (1) and a second region (5), different from the first region, has a second cutting blade arrangement (4). First and second regions are separated by intermediate web (7). Foodstuff chopping apparatus includes cutting insert (1) and ram attached to pivoting region which are realisably attached to a vessel.
Patent NZ-622127-A (NZ)
Title: Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
Inventor: WIRTH KLAUS
IPC: C07F9/6553
Filed: 2012-09-10
Abstract: Provided are substituted 2-(chroman-6-yloxy)-thiazole compounds of the general formula I, where the variables are as defined in the specification. Examples of the compounds include 2-(2-o-Tolyl-chroman-6-yloxy)-thiazole-5-carboxylic acid [2-(2-oxo-imidazolidin-1-yl)ethyl]-amide and [2-(2-Phenyl-chroman-6-yloxy)-thiazol-5-ylmethyl]-pyridin-4-ylmethyl-amine. The compounds sodium-calcium exchanger (NCX) inhibitors. The compounds may be useful in the treatment of arrhythmias, heart failure and stroke.
Patent NZ-624128-A (NZ)
Title: Aerosol generating device with heater assembly
Inventor: PLOJOUX JULIEN
IPC: A24F40/20
Filed: 2012-10-24
Abstract: An aerosol generating device, comprises a housing 100 configured to receive an aerosol-forming substrate 180 having an internal cavity, a heater 140, the heater 140 configured to be received within the internal cavity of the aerosol-forming substrate 180, and a positioner 210 coupled to the heater 140. The positioner 210 is configured to move the heater 140 between a plurality of positions within the internal cavity.
Patent NZ-630760-A (NZ)
Title: A method of providing ocular neuroprotection
Inventor: MCVICAR WILLIAM K
IPC: A61P27/02
Filed: 2014-03-14
Abstract: Provided are methods of protecting retinal ganglion cells and providing ocular neuroprotection by administering selective adenosine A1 agonists of the general formula (I), wherein the variables are as defined in the specification. A preferred selective adenosine A1 agonist is ((2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl nitrate.
Patent NZ-700897-A (NZ)
Title: Lowering saturated fatty acid content of plant seeds
Inventor: BEVAN SCOTT
IPC: C12P7/64
Filed: 2011-06-24
Abstract: Disclosed is a recombinant, synthetic or isolated nucleic acid molecule encoding a delta-9 desaturase enzyme comprising an amino acid sequence that is at least 80% identical to SEQ ID NO:14, wherein the nucleic acid molecule further comprises a gene regulatory element. The sequence identity is as defined in the specification. Also disclosed is a method for decreasing the amount of saturated fatty acids in a plant cell by the use of above disclosed nucleic acid molecule.
Patent NZ-702907-A (NZ)
Title: Laver-snack made of laver and cereal sheets and process of producing the same
Inventor: CHUNG SUYEON
IPC: A23G3/54
Filed: 2013-11-25
Abstract: Provided is a laver-snack produced by attaching a cereal sheet to a laver sheet to obtain a double-layer sheet and then roasting the double-layer sheet, and a method of producing the laver-snack.
Patent NZ-706946-A (NZ)
Title: Application hosting within a secured framework in a fueling environment
Inventor: CARAPELLI GIOVANNI
IPC: G07G1/00
Filed: 2013-09-23
Abstract: A secured framework for hosting secure and non-secure applications is provided. A master control apparatus includes an interface component for providing input to or output from the master control apparatus, and an interface communicating component for establishing a communications path to a portion of the interface component when a secured portion of the interface component is active. The interface communicating component provides data from a feature apparatus to the portion of the interface component over the communications path, and switches the communications path to refrain from providing data from the feature apparatus where the secured portion of the interface component is active. A security analyzing component can also be included to additionally or alternatively determine whether access is allowed to the portion of the interface component.
Patent NZ-710546-A (NZ)
Title: Control system for a refrigerated merchandiser
Inventor: REES BRIAN J
IPC: F25D21/04
Filed: 2013-05-24
Abstract: Disclosed is a refrigerated merchandiser (10) configured to prevent frost build-up on a coil (125) of an evaporator (85). The merchandiser (10) comprises a case defining a product display area and including an air outlet and an air passageway in fluid communication with the product display area via the outlet to direct an airflow into the product display area to condition product supported in the product display area. The merchandiser (10) also includes at least a portion of a refrigeration system (75) including an evaporator (85) disposed in the case within the air passageway to refrigerate the airflow, the evaporator (85) having a coil (125) with a hydrophobic coating. The refrigeration system (75) further includes a compressor (90) in fluid communication with the evaporator (85) and a control system (not shown) in communication with and programmed to control the evaporator (85) within a predetermined evaporating temperature range to condition the product display area within a predetermined temperature range. The control system is further programmed to selectively cycle the compressor (90) between an on state and an off state at least once during a predetermined time period to avoid formation of frost on the coil (125) while maintaining the product display area within the predetermined temperature range.
Patent NZ-713996-A (NZ)
Title: Method of prolonging use of a driver blade in a fastening tool
Inventor: HORST CHRISTOPHER A
IPC: F16B33/06
Filed: 2010-09-22
Abstract: A fastener (210) and a method for reducing wear on a driver blade in a fastening tool includes applying a layer of solid-based lubricant (216) between the head of a fastener and a driver blade end. The fastener is for use in a fastening tool and includes a head (214), a shank (212), and a Iayer of lubricant (216) on the head (214) of the fastener. The lubricant is graphite, molybdenum disulfide, tungsten disulfide, boron nitride, polytetrafluoroethylene (PTFE), nano-diamonds, calcium stearate, sodium stearate, oils, greases, waxes, thermoplastic polymers, or another lubricant that exhibits similar characteristics, Aromatic polyamides, ultra-high molecular weight polyethylene, powdered glass, glass fibers, thermoplastic polymers, and thermoset polymers also are contemplated to provide a barrier to contact between the driver blade and fastener head. The lubricant is sprayed, rolled, brushed, blotted or otherwise applied between the head of the fastener and the driver blade end prior to firing the fastening tool.
Patent NZ-721425-A (NZ)
Title: Method and apparatus for treating alkaline water containing solids
Inventor: COULTON RICHARD
IPC: C02F1/66
Filed: 2014-11-28
Abstract: Method and apparatus for treating alkaline water containing solids. An apparatus and method of treating alkaline water employs a neutralisation unit (3), including a store (15) of neutralising agent. A first container (1) receives alkaline water to be treated and a second container (2) receives alkaline water from the first container (1). Neutralising agent is fed from the store (15) into the second container (2) to reduce the pH of the alkaline water fed to the second container (2) from the first container (1). The first and second containers (1, 2) and the neutralisation unit (3) are separate portable units, allowing for improved transportability of the apparatus.
Patent NZ-728301-A (NZ)
Title: Extraction of products from titanium-bearing minerals
Inventor: HASSELL DAVID JONATHAN
IPC: C22B34/12
Filed: 2015-07-08
Abstract: The invention relates to a process for extracting metals and salts from titanium-bearing minerals such as perovskite. More particularly, although not exclusively, the invention relates to extracting titanium dioxide and optionally other compounds from melter slag derived from an iron-making process. More particularly, although not exclusively, the invention relates to a method of recovering titanium dioxide, aluminium sulphate and magnesium sulphate from a particulate material, said method comprising: a. contacting the particulate material with sulphuric acid and heating to form a sulphated mixture; b. filtering the sulphated mixture to produce a filter cake and a first permeate comprising sulphuric acid; c. contacting the filter cake with water to form a sulphated suspension comprising titanyl sulphate; d. filtering the sulphated suspension to produce a permeate comprising at least titanyl sulphate, and a retentate comprising insoluble residue; e. contacting the permeate comprising at least titanyl sulphate with water to produce a hydrolysis liquor; and f. hydrolysing the titanyl sulphate; g. separating titanium dioxide hydrate from the hydrolysis liquor to produce a permeate comprising aluminium sulphate and magnesium sulphate, and a retentate comprising titanium dioxide hydrate; and h. precipitating aluminium sulphate from the permeate; i. precipitating magnesium sulphate from the permeate; wherein step h. may be carried out after step d or after step g.
Patent NZ-739018-A (NZ)
Title: Method for controlling an adsorption phase of a gas generator and a gas generator applying such a method
Inventor: COREMANS TOM
IPC: B01D53/04
Filed: 2016-05-31
Abstract: The present invention is related to a method for controlling an adsorption phase of a gas generator, said generator comprising at least one vessel comprising an inlet and an outlet for allowing a flow of gas therethrough and an adsorbent medium capable of selectively adsorbing a first gaseous component from a gaseous mixture, and allowing an outlet gas flow mainly comprising a second gaseous component, said method comprising the steps of: - directing the inlet gas flow through an inlet of said vessel; - measuring the volume of the second gaseous component per unit of time with a flow meter positioned at the outlet of said vessel; - determining the concentration of said second gaseous component at the outlet of said vessel, wherein the method further comprises the steps of: A1) calculating the capacity of the vessel; A2) comparing the measured volume of the second gaseous component per unit of time with the calculated capacity; A3) if the measured volume of the second gaseous component per unit of time is lower than the calculated capacity, and if the determined concentration is higher than or equal to a set value, maintaining the vessel in adsorption phase for a predetermined time interval, ∆s; A4) subjecting the generator to a regenerating cycle after said predetermined time interval, ∆s. An object of this invention is to provide a method to control an adsorption phase of a gas generator, during which the concentration of a gaseous component is maintained at a desired level, while at the same time, the energy consumption of the adsorption process is decreased. This is achieved as this control is based on a combination of the concentration of the second gaseous component at the outlet of the vessel and the volume of the second gaseous component per unit of time at the outlet of said vessel.
Patent NZ-748769-A (NZ)
Title: Nitroxyl donors with improved therapeutic index
Inventor: KALISH VINCENT JACOB
IPC: C07D307/64
Filed: 2014-01-17
Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds of formula (3), pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
Patent NZ-759032-A (NZ)
Title: Ventilatable valve bag
Inventor: REPP WALDEMAR
IPC: B65D33/01
Filed: 2018-05-23
Abstract: A ventilatable valve bag (2) made from a wall material (4) with two layers of plastic. The inner layer (6) is gas-permeable but impermeable to the filling material, and the outer layer (8) is gas-impermeable. The bag has two closing sides, with a first closing side (10) formed by folding the wall material, and a second closing side opposite the first closing side. An intermediate space (14) is formed between a part of the inner layer and the outer layer, defining an inner space (12) of the bag . At least one ventilation channel (18) is constructed in an outer side fold (20) of at least one closure side, the channel leading out of a wall material edge section (16) between the inner layer and the outer layer. The invention provides a stable and operationally reliable means for ventilating sacks by arranging the valve mouth away from sealing seams and areas that can be prone to blockage when sacks are stacked upon each other.